A $4.9 billion hole has appeared in Gilead’s pipeline. After years of setbacks, the big biotech dealt a final blow to its ...

One of Chris Boerner’s first tours as the new CEO of Bristol Myers Squibb was of a 256,000 square-foot research facility in ...

Medtronic has secured FDA approval for its first closed-loop spinal cord stimulator, designed to take in signals from the ...

Last year was a difficult one for ex-Stanford president Marc Tessier-Lavigne, Ph.D. An investigation into his prior research ...

After hanging out the for sale sign and filing for bankruptcy ear | According to Invitae the transaction covers ...

If you asked an AI to generate a brand-new drug discovery biotech with a team of some of the biggest names in the biz for you ...

Bristol Myers Squibb is the latest large pharma to wield the restructuring ax, with plans to cut $1.5 billion in costs by the ...

In recent years, artificial intelligence programs for drug design have steadily shown they can help explore far beyond just ...

As a whole, Boston Scientific reported a 13.8% increase in quarterly revenue, for $3.86 billion in net sales. That outpaced ...

The culls are part of a broader refocusing that has removed 20% of new molecules from the pipeline in recent quarters.

The twin clinical testing giants Labcorp and Quest Diagnostics have each, in the past week, added to their portfolios new ...

Parexel has struck a multi-year deal with Palantir Technologies to integrate its artificial intelligence systems into Parexel ...